Pramaana Labs has closed a $27 million seed round led by Khosla Ventures, with funding directed toward building a formal verification layer for AI systems deployed in legal and healthcare settings, according to TechCrunch and Crypto Briefing, both reporting on June 17, 2026.

A $27 million seed round is outsized for this stage. The size signals that Khosla—a firm known for backing infrastructure plays early—sees this as a structural market need, not a gap in existing product features.

The Problem

The problem Pramaana is addressing is clearly defined, though solutions have proved difficult. Formal verification is a mathematical technique borrowed from hardware and safety-critical software engineering. It uses proof methods to guarantee that a system will behave according to its spec under all possible inputs, not merely the ones you happened to test. Applied to large language models and AI inference pipelines, this becomes genuinely hard: the number of possible states is vast, model outputs are probabilistic rather than deterministic, and the "spec" for what a legal or medical AI should do shifts across jurisdictions and professional contexts.

Healthcare and law are the two industries where AI mistakes are least forgivable. A wrong diagnosis suggestion can harm a patient. A missed drug-interaction flag can be fatal. A contract clause that an AI misinterprets or invents exposes firms to liability that vendor indemnification will not cover. Practitioners in both sectors have been explicit about this concern. Regulators in the EU, UK, and increasingly the US now treat AI outputs in high-stakes contexts as a compliance obligation, not just a product feature.

What "Formal Verification for AI" Actually Means

Traditional software verification—tools like TLA+, Coq, or Isabelle—works on code whose logic can be mapped out symbolically. Neural networks do not reduce to symbolic logic neatly. In practice, "formal verification for AI" most likely means a hybrid approach: wrapping model inference with constraint-checking layers, deploying verified runtime monitors that check outputs against a formal spec, or applying verified fine-tuning bounds so that a model stays within a provably safe range for a defined set of inputs. None of these fully solves the general problem, but each meaningfully shrinks the tail-risk that makes enterprise procurement teams in regulated industries hesitant to deploy AI at scale.

That hesitation is the market Pramaana is going after. Large health systems and law firms have compliance budgets for this. They also have compliance officers who translate "formal verification" into procurement language—"auditable guarantees"—in ways that resonate with boards and insurers. The sales channel runs through enterprise risk and security teams, not consumer marketing.

Why Khosla Is Betting Here

Khosla Ventures has a pattern of backing infrastructure bets early when application-layer activity creates a new critical dependency. The logic here follows that playbook: as AI adoption spreads through law and healthcare, the verification and auditability layer becomes essential to production deployment. Entering at seed gives Khosla position before that layer consolidates.

What Pramaana has not disclosed publicly—at least as of this reporting—is the specific technical architecture, any existing customer relationships, or the founding team's background. Those details matter greatly for assessing whether the formal-verification framing is substantive or marketing language. Seed-stage opacity is standard, but the gap between "we are building formal verification for AI" and a shipping product that a hospital or law firm can deploy before their compliance team is considerable.

The $27 million runway allows Pramaana to hire deep technical talent—formal methods researchers are a small community—and to pursue the slow, relationship-driven sales cycles that regulated industries demand. The real test will be whether the mathematics holds at production scale across the range of models and use cases that real-world deployments involve.